Skip to main content
. 2024 Feb 13;14:1336619. doi: 10.3389/fcimb.2024.1336619

Figure 1.

Figure 1

The patients’ flowchart. HCC, hepatocellular carcinoma; HAIC, hepatic arterial infusion chemotherapy; PD1s, programmed death receptor-1 signaling inhibitors; HCV, hepatitis C virus; Anti-HBc, antibody to hepatitis B coreantigen; HBV, hepatitis B virus.